313 related articles for article (PubMed ID: 8816130)
1. European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans.
Strle F; Nelson JA; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Cheng Y; Picken MM; Trenholme GM; Picken RN
Clin Infect Dis; 1996 Jul; 23(1):61-5. PubMed ID: 8816130
[TBL] [Abstract][Full Text] [Related]
2. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
Nadelman RB; Nowakowski J; Forseter G; Goldberg NS; Bittker S; Cooper D; Aguero-Rosenfeld M; Wormser GP
Am J Med; 1996 May; 100(5):502-8. PubMed ID: 8644761
[TBL] [Abstract][Full Text] [Related]
3. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
[TBL] [Abstract][Full Text] [Related]
4. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606
[TBL] [Abstract][Full Text] [Related]
6. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia.
Strle F; Nadelman RB; Cimperman J; Nowakowski J; Picken RN; Schwartz I; Maraspin V; Aguero-Rosenfeld ME; Varde S; Lotric-Furlan S; Wormser GP
Ann Intern Med; 1999 Jan; 130(1):32-6. PubMed ID: 9890847
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
8. Isolation and species typing of Lyme borreliosis spirochaetes from UK patients with erythema migrans.
Robertson J; Murdoch S; Foster L; Green S
Eur J Epidemiol; 1999 May; 15(5):499-500. PubMed ID: 10442477
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions.
Strle F; Cheng Y; Cimperman J; Maraspin V; Lotric-Furlan S; Nelson JA; Picken MM; Ruzic-Sabljic E; Picken RN
Clin Infect Dis; 1995 Aug; 21(2):380-9. PubMed ID: 8562748
[TBL] [Abstract][Full Text] [Related]
10. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients.
Kuiper H; Cairo I; Van Dam A; De Jongh B; Ramselaar T; Spanjaard L; Dankert J
Br J Dermatol; 1994 Apr; 130(4):466-72. PubMed ID: 8186111
[TBL] [Abstract][Full Text] [Related]
11. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
[TBL] [Abstract][Full Text] [Related]
12. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
Picken MM; Picken RN; Han D; Cheng Y; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Strle F
Mol Pathol; 1997 Aug; 50(4):186-93. PubMed ID: 9350301
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of 10 cases of Lyme disease presenting with erythema migrans in Istanbul, Turkey].
Akın Belli A; Derviş E; Özbaş Gök S; Midilli K; Gargılı A
Mikrobiyol Bul; 2015 Oct; 49(4):525-31. PubMed ID: 26649410
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.
Zore A; Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Pikelj A; Jurca T; Logar M; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):606-9. PubMed ID: 12422609
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
Smith RP; Schoen RT; Rahn DW; Sikand VK; Nowakowski J; Parenti DL; Holman MS; Persing DH; Steere AC
Ann Intern Med; 2002 Mar; 136(6):421-8. PubMed ID: 11900494
[TBL] [Abstract][Full Text] [Related]
16. [Borrelia strains that cause erythema migrans in Alsace, France].
Antoni-Bach N; Jaulhac B; Hansmann Y; Limbach F; Lipsker D
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):15-8. PubMed ID: 11937923
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of Lyme borreliosis.
Berger BW
Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
[TBL] [Abstract][Full Text] [Related]
18. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.
Berger BW; Johnson RC; Kodner C; Coleman L
J Clin Microbiol; 1992 Feb; 30(2):359-61. PubMed ID: 1537904
[TBL] [Abstract][Full Text] [Related]
19. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
Maraspin V; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
[TBL] [Abstract][Full Text] [Related]
20. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study.
Nadelman RB; Nowakowski J; Forseter G; Bittker S; Cooper D; Goldberg N; McKenna D; Wormser GP
Am J Med; 1993 Jun; 94(6):583-8. PubMed ID: 8506882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
